Practice Point® CME Podcasts: Expert Discussions in Immunology™

Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

24 min · 27 de mar de 2025
Portada del episodio Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

Descripción

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast [https://www.practicepointcme.com/CMEHome/conversations-in-psoriasis-and-psoriatic-arthritis-evolving-strategies-in-pso-and-psa-a-clinical-guide-for-optimized-patient-care-1].

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Practice Point® CME Podcasts: Expert Discussions in Immunology™!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

16 episodios

episode Episode 16 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Patient-Centered Care Podcast - Part 3 artwork

Episode 16 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Patient-Centered Care Podcast - Part 3

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast [https://www.practicepointcme.com/CMEHome/conversations-in-psoriasis-and-psoriatic-arthritis-evolving-strategies-in-pso-and-psa-a-clinical-guide-for-optimized-patient-care-1].

27 de mar de 202527 min
episode Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2 artwork

Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast [https://www.practicepointcme.com/CMEHome/conversations-in-psoriasis-and-psoriatic-arthritis-evolving-strategies-in-pso-and-psa-a-clinical-guide-for-optimized-patient-care-1].

27 de mar de 202524 min
episode Episode 14 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Personalized Treatment Strategies Podcast - Part 1 artwork

Episode 14 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Personalized Treatment Strategies Podcast - Part 1

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast [https://www.practicepointcme.com/CMEHome/conversations-in-psoriasis-and-psoriatic-arthritis-evolving-strategies-in-pso-and-psa-a-clinical-guide-for-optimized-patient-care-1].

27 de mar de 202524 min
episode Episode 13 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Part 2: Vitiligo: No Decision About Me Without Me artwork

Episode 13 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Part 2: Vitiligo: No Decision About Me Without Me

Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo. Launch Date: November 21, 2024 Release Date: November 21, 2024 Expiration Date: October 31, 2025 FACULTY Raj Chovatiya, MD, PhD, MSCI, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago, IL This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo [https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo]

23 de ene de 202526 min
episode Episode 12 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Part 1: Personalized Care: Treating Individuals with Vitiligo artwork

Episode 12 - Ask the Expert: Emerging Evidence to Improve Outcomes in Vitiligo - Part 1: Personalized Care: Treating Individuals with Vitiligo

Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo. Launch Date: November 14, 2024 Release Date: November 14, 2024 Expiration Date: October 31, 2025 FACULTY Raj Chovatiya, MD, PhD, MSCI, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago, IL This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo [https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo]

23 de ene de 202523 min